title: Identification of the neurotransmitter/neuromodulator functions of the neuropeptide gastrin-releasing peptide in the porcine antrum, using the antagonist (Leu13-psi-CH2 NH-Leu14)-bombesin.
abstract: We studied the effects of a new bombesin/gastrin-releasing peptide (GRP) receptor antagonist, Leu13-psi-(CH2NH)-Leu14-bombesin, on the secretion of gastrin and somatostatin and on the motor activity of isolated perfused porcine antrum in response to infusions of GRP at 10(-10) or 10(-9) mol/l and in response to electric stimulation of the vagus nerves. GRP significantly increased the secretion of gastrin and somatostatin and increased the frequency of antral contractions threefold. At 0.5 x 10(-6) mol/l the antagonist completely abolished the effects on motality and gastrin secretion and strongly inhibited the effect on somatostatin secretion. Vagus stimulation significantly increased gastrin and somatostatin secretion and increased the contraction frequency threefold. The antagonist strongly inhibited the somatostatin response, abolished the motility effects and reversed the stimulatory effect on gastrin secretion to a significant inhibition. Assuming that the antagonist interacts specifically with GRP receptors, we conclude that our data strongly support the concept that GRP-producing nerves are essential for vagally induced secretion of gastrin and somatostatin from the antrum. The GRP nerves may also play a role in the control of gastric motor activity.
authors.affiliation: Institute of Medical Physiology, C, Panum Institute, Denmark.
authors.forename: J J
authors.initials: JJ
authors.lastname: Holst
authors.forename: H
authors.initials: H
authors.lastname: Harling
authors.forename: T
authors.initials: T
authors.lastname: Messell
authors.forename: D H
authors.initials: DH
authors.lastname: Coy
mesh_terms: D000818:Animals; D001839:Bombesin / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D019886:Gastrin-Releasing Peptide; D005755:Gastrins / Q000378:metabolism; D005768:Gastrointestinal Hormones / Q000037:antagonists & inhibitors / Q000502:physiology*; D005769:Gastrointestinal Motility / Q000502:physiology; D018377:Neurotransmitter Agents / Q000502:physiology; D010455:Peptides / Q000037:antagonists & inhibitors / Q000502:physiology*; D011706:Pyloric Antrum / Q000294:innervation; D018004:Receptors, Bombesin; D017981:Receptors, Neurotransmitter / Q000187:drug effects; D013004:Somatostatin / Q000378:metabolism; D013552:Swine; D014630:Vagus Nerve / Q000502:physiology
chemical_list: D005755:Gastrins; D005768:Gastrointestinal Hormones; D018377:Neurotransmitter Agents; D010455:Peptides; D018004:Receptors, Bombesin; D017981:Receptors, Neurotransmitter; C057644:bombesin, Leu(13)-psi-CH2NH-Leu(14)-; D013004:Somatostatin; D019886:Gastrin-Releasing Peptide; D001839:Bombesin